Silvercrest Asset Management Group LLC Astrazeneca PLC Transaction History
Silvercrest Asset Management Group LLC
- $13.6 Billion
- Q1 2025
A detailed history of Silvercrest Asset Management Group LLC transactions in Astrazeneca PLC stock. As of the latest transaction made, Silvercrest Asset Management Group LLC holds 322,208 shares of AZN stock, worth $23.5 Million. This represents 0.17% of its overall portfolio holdings.
Number of Shares
322,208
Previous 288,071
11.85%
Holding current value
$23.5 Million
Previous $18.9 Million
25.47%
% of portfolio
0.17%
Previous 0.13%
Shares
12 transactions
Others Institutions Holding AZN
# of Institutions
1,428Shares Held
504MCall Options Held
10MPut Options Held
3.14M-
Price T Rowe Associates Inc Baltimore, MD57.1MShares$4.16 Billion0.52% of portfolio
-
Primecap Management CO Pasadena, CA40.7MShares$2.96 Billion2.53% of portfolio
-
Wellington Management Group LLP Boston, MA35.6MShares$2.59 Billion0.52% of portfolio
-
Bank Of America Corp Charlotte, NC31.8MShares$2.32 Billion0.19% of portfolio
-
Capital International Investors Los Angeles, CA31.3MShares$2.28 Billion0.47% of portfolio
About ASTRAZENECA PLC
- Ticker AZN
- Exchange OTC
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 3,099,020,032
- Market Cap $226B
- Description
- AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...